Desjardins Global Asset Management’s Boston Scientific BSX Stock Holding History

Desjardins Global Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$2.48M	Buy	42,868 +459	+1%	+$24.5K	0.27%	79
2023 Q3	$2.24M	Buy	42,409 +9,541	+29%	+$500K	0.24%	81
2023 Q2	$1.78M	Buy	32,868 +22,120	+206%	+$1.16M	0.2%	114
2023 Q1	$538K	Buy	10,748 +6,346	+144%	+$299K	0.07%	234
2022 Q4	$203K	Buy	4,402 +52	+1%	+$2.25K	0.03%	341
2022 Q3	$168K	Buy	4,350 +145	+3%	+$5.82K	0.02%	357
2022 Q2	$156K	Sell	4,205 -171	-4%	-$6.96K	0.02%	362
2022 Q1	$193K	Sell	4,376 -266	-6%	-$11.5K	0.02%	358
2021 Q4	$197K	Buy	+4,642	New	+$195K	0.02%	364

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Desjardins Global Asset Management's BSX Position: Q4 2023 in Review

Desjardins Global Asset Management increased its Boston Scientific (BSX) stake by 1.1% in Q4 2023, buying an estimated $24.5K and bringing the position to 42,868 shares worth $2.48M. The position accounts for 0.27% of the portfolio, ranked #79.

Desjardins Global Asset Management first reported a position in BSX in Q4 2021 and has held it in 9 quarters since. 1,148 funds tracked by Wall St. Rank hold BSX as of Q4 2023.

Desjardins Global Asset Management held 42,868 shares of Boston Scientific worth $2.48M as of Q4 2023.
Desjardins Global Asset Management bought 459 Boston Scientific shares in Q4 2023, an estimated $24.5K.
Boston Scientific made up 0.27% of Desjardins Global Asset Management's portfolio in Q4 2023, its #79 holding.
Desjardins Global Asset Management first reported a position in Boston Scientific in Q4 2021 and has held it in 9 quarters since.
1,148 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.